Adolescent nutrition is at a turning point. 🌍

Dr Sara Estecha-Querol from the Global Adolescent Nutrition Network and youth advocate Milca Jane Cameseria from Act4Food join Josefine Gibson to talk about a new co-created global framework for adolescent nutrition — and why young people must be at the centre of adolescent nutrition research, policy, advocacy, and food systems change. Together, we explore the global triple burden of malnutrition, meaningful youth partnership, sustainable food systems, and the urgent need for coordinated action to improve adolescent health and wellbeing worldwide.

🎧 Tune in for a conversation on global health, nutrition equity, youth leadership, and the future of adolescent nutrition.

Click here to read the full article:

https://www.thelancet.com/journals/lanchi/article/PIIS2352-4642(26)00012-X/fulltext

This episode considers how antibiotic use can be safely reduced in children in high-risk scenarios or with severe infections. To discuss this we are joined by Dr Nadja Vissing and Dr Ulrikka Nygaard, paediatric infectious disease specialists from Copenhagen University Hospital, who led a randomized controlled trial in Denmark evaluating the early discontinuation of empirical antibiotics versus extended treatment in children with cancer and high-risk febrile neutropenia. We hear about the importance of this trial for children with cancer and their families as well as for broader antimicrobial stewardship.

We discuss other recent RCTs that are informing safely reducing antibiotic exposure in children with urinary tract infections, uncomplicated bone and joint infections and probable early onset neonatal sepsis. Nadja and Ulrikka share with listeners their take home messages related to antibiotic decision-making from these trials along with words of wisdom and motivation for other paediatric clinical trialists.

Click here to read the full article:

https://www.thelancet.com/journals/lanchi/article/PIIS2352-4642(26)00039-8/fulltext

Controlled medicines are essential in paediatric care yet children everywhere—and especially in low- and middle-income countries—face challenges in accessing controlled medicines for their medical needs and to alleviate serious health-related suffering.

In this episode, Belén Tarrafeta and Hazel Gutiérrez join Josefine Gibson to discuss misconceptions that have led to children’s access being overlooked in research and policy efforts. Together, they highlight the imperative of generating child-specific evidence on access, safety, and use, and they explore what it will take to move from global resolutions to real change for children's equitable access to controlled medicines.

Click here to read the full articles:

Review: https://www.thelancet.com/journals/lanchi/article/PIIS2352-4642(25)00374-8/fulltext

Health Policy: https://www.thelancet.com/journals/lanchi/article/PIIS2352-4642(25)00375-X/fulltext